Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit

Metformin is the first-line medication for type 2 diabetes, but it also has a long history of improved outcomes in infectious diseases, such as influenza, hepatitis C, and in-vitro assays of zika. In the current Covid-19 pandemic, which has rapidly spread throughout the world, 4 observational studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Sherehan, Lowe, Jamie R., Bramante, Carolyn T., Shah, Surbhi, Klatt, Nichole R., Sherwood, Nancy, Aronne, Louis, Puskarich, Michael, Tamariz, Leonardo, Palacio, Ana, Bomberg, Eric, Usher, Michael, King, Samantha, Benson, Brad, Vojta, Deneen, Tignanelli, Chris, Ingraham, Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342037/
https://www.ncbi.nlm.nih.gov/pubmed/34367059
http://dx.doi.org/10.3389/fendo.2021.587801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342037/
https://www.ncbi.nlm.nih.gov/pubmed/34367059
http://dx.doi.org/10.3389/fendo.2021.587801

Ejemplares similares